Angiotensin II mediates most of the biological effects of the renin-angiote
nsin system (RAS), such as vasoconstriction and cell proliferation, via sti
mulation of the angiotensin II type 1 (AT1) receptor. The AT1 receptor play
s a central role in the pathogenesis of atherosclerosis and hypertension. I
n parallel, hypercholesterolaemia is a major risk factor for the developmen
t and progression of cardiovascular diseases. The underlying molecular even
ts, however, are understood only partially. An important mechanism may be t
he interaction between hypercholesterolaemia and AT1 receptor expression in
vascular tissue. Low-density lipoprotein (LDL) cholesterol leads to a prof
ound increase in AT1 receptor expression in cultured vascular smooth muscle
cells as well as in hypercholesterolaemic rabbits. This up-regulation is a
ssociated with an enhanced functional response upon stimulation with angiot
ensin II. Over-expression of the vascular AT1 receptor can also be observed
in hypercholesterolaemic men and is prevented by treatment with 3-hydroxy-
3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. These findings
may explain why hypercholesterolaemia is frequently associated with hyperte
nsion and why blockade of the RAS attenuates the progression of atheroscler
osis.